Effect of Pre-emptive Assessment of Self-care Peritoneal Dialysis (PD) Ability on PD Choice in Patients With Stage 5 Chronic Kidney Disease
NCT ID: NCT04967547
Last Updated: 2021-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
232 participants
INTERVENTIONAL
2022-01-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis
NCT02755610
The Mobile-based Training System in Peritoneal Dialysis Patients
NCT06876987
Characteristics and Clinical Outcomes of Peritoneal Dialysis Patients
NCT05224466
Urgent-start Peritoneal Dialysis in ESRD Patients：A Multi-center Study
NCT02946528
Different Retraining Methods vs Usual Care on the Prevention of Peritonitis in Peritoneal Dialysis
NCT01621997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
be evaluated by using the self-care PD feasibility assessment in addition to education on renal replacement therapy and dialysis
Self-care PD ability assessment form
Subjects will be evaluated using the self-care PD feasibility assessment tool within 7 days after randomization. The evaluation results will be provided to the patient on the same day
Education
Education on renal replacement therapy and dialysis
Control group
education on renal replacement therapy and dialysis
Education
Education on renal replacement therapy and dialysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self-care PD ability assessment form
Subjects will be evaluated using the self-care PD feasibility assessment tool within 7 days after randomization. The evaluation results will be provided to the patient on the same day
Education
Education on renal replacement therapy and dialysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Need dialysis within 6 months;
3. Informed consent.
Exclusion Criteria
2. Need urgent dialysis;
3. RTX as initial renal replacement therapy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Jiao Tong University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Na Jiang
Department of Nephrology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wei Fang, MD
Role: STUDY_DIRECTOR
RenJi Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
self-care PD ability
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.